NCT05082779
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159 treatment 1 completed NCT01672853
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) prevention 2 completed NCT06037577
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects treatment 1 completed NCT03333928
A POC and Dose-Ranging Study of HTD1801 in PSC Patients No drug interventions treatment 2 completed NCT02177136
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) treatment 2 completed NCT06026865
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC) No drug interventions treatment Not Available recruiting NCT01695174
A Pilot Study of Xifaxan to Treat Patients With PSC treatment 1 completed NCT01161992
Genomics of Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available active_not_recruiting NCT03766035
Cholangioscopy in Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available completed NCT01819766
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease No drug interventions Not Available Not Available completed NCT02061540
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis treatment 2 completed NCT02808312
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function treatment 1 completed NCT04663308
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) treatment 2 recruiting NCT05627362
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. treatment 2 active_not_recruiting NCT05642468
Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis treatment 2 recruiting NCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach No drug interventions Not Available Not Available recruiting NCT06095986
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis treatment 2 suspended NCT03099603
A Study of HTD1801 in Healthy Subjects No drug interventions treatment 1 completed NCT02704364
Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis treatment 2 completed NCT03561584
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis treatment 2 recruiting NCT05912387
Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study basic_science 0 recruiting NCT01798953
Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis No drug interventions Not Available Not Available completed NCT05463445
Multicenter Observational Study of PSC and IgG4-SC in China No drug interventions Not Available Not Available unknown_status NCT05750498
A-LiNK: Improving Outcomes in Autoimmune Liver Disease No drug interventions Not Available Not Available recruiting NCT05462093
Clinical Application of Annual Liver Multiscan and MRCP+ in Primary Sclerosing Cholangitis No drug interventions diagnostic Not Available not_yet_recruiting NCT03175471
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease No drug interventions Not Available Not Available recruiting NCT01088607
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis treatment 1 completed NCT05866809
Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis treatment 2 completed NCT06286709
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis No drug interventions treatment 2 recruiting NCT04981756
PSC Clinical Epidemiology in China No drug interventions Not Available Not Available active_not_recruiting NCT03445585
Biobank for Cholestatic Liver Diseases. No drug interventions Not Available Not Available recruiting NCT00953615
Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) treatment 2 terminated NCT00630942
Minocycline in Primary Sclerosing Cholangitis (PSC) treatment 1 completed NCT01880606
Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance No drug interventions Not Available Not Available completed NCT03516006
Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis treatment 1 / 2 unknown_status NCT06026449
Gluten-free Diet in PSC and IBD No drug interventions treatment Not Available recruiting NCT02605213
Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients treatment 4 unknown_status NCT04024813
A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC treatment 2 completed NCT00325013
Evaluation of DHA for the Treatment of PSC treatment 1 completed NCT01398917
Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis No drug interventions treatment 3 unknown_status NCT02247934
Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available completed NCT03951324
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study No drug interventions Not Available Not Available unknown_status NCT00588458
The Value of CT Cholangiography in Primary Sclerosing Cholangitis No drug interventions Not Available 2 withdrawn NCT01322386
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin treatment 1 completed NCT03710122
Vancomycin for Primary Sclerosing Cholangitis treatment 2 / 3 active_not_recruiting NCT02653625
PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis treatment 2 completed NCT04595825
CM-101 in PSC Patients -The SPRING Study treatment 2 active_not_recruiting NCT03178630
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease No drug interventions Not Available Not Available recruiting NCT00161148
Probiotics in Patients With Primary Sclerosing Cholangitis No drug interventions treatment 3 unknown_status NCT02884557
NKT Role in the Regulation of the Inflammatory Bowel Disease No drug interventions basic_science Not Available completed NCT03337074
Paternally Inherited Phenotypes in Cholestasis No drug interventions Not Available Not Available unknown_status NCT03890120
Study of Cilofexor in Adults With Primary Sclerosing Cholangitis treatment 3 terminated NCT01802073
Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects treatment 3 completed NCT04309773
Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy treatment 3 recruiting NCT03041662
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available completed NCT06455280
SIPLIZUMAB in AILD and LT treatment 1 not_yet_recruiting NCT03678480
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) treatment 2 withdrawn NCT04480840
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) treatment 2 completed NCT03743272
Repeatability and Reproducibility of Multiparametric MRI No drug interventions Not Available Not Available unknown_status NCT01556412
Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis No drug interventions Not Available Not Available completed NCT04015310
Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study No drug interventions Not Available Not Available withdrawn NCT01549795
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy treatment Not Available unknown_status NCT00476814
NPD Measurements in PSC Patients No drug interventions Not Available Not Available unknown_status NCT01142323
Pilot Study of Fenofibrate for PSC treatment 1 / 2 terminated NCT04181138
Primary Sclerosing Cholangitis in Children No drug interventions Not Available Not Available recruiting NCT03872921
norUrsodeoxycholic Acid vs Placebo in PSC treatment 3 active_not_recruiting NCT00059202
Trial of High-dose Urso in Primary Sclerosing Cholangitis treatment 2 / 3 terminated NCT04060147
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis treatment 1 terminated NCT05618145
National Database on Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available recruiting NCT05835505
Detoxification of the Liver In PSC (Dolphin) No drug interventions treatment 2 recruiting NCT05376228
A Systems Biology Approach for Identification of Host and Microbial Mechanisms and Druggable Targets for the Treatment of PSC-IBD Not Available Not Available unknown_status NCT02239211
A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis treatment 2 completed NCT01755507
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis No drug interventions treatment 2 completed NCT05896137
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) treatment 2 recruiting NCT05181332
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis No drug interventions Not Available Not Available recruiting NCT03809559
Repeatability and Reproducibility of Quantitative MRCP No drug interventions Not Available Not Available completed NCT03183570
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT No drug interventions diagnostic 0 recruiting NCT00955149
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) prevention 1 completed NCT02712736
Quality of Life in Patients With Primary Sclerosing Cholangitis No drug interventions other Not Available completed NCT04678219
A Pilot Study Examining Diet in Primary Sclerosing Cholangitis No drug interventions treatment Not Available unknown_status NCT06061341
TruGraf Liver Gene Expression Serial Test No drug interventions Not Available Not Available enrolling_by_invitation NCT01688024
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis treatment 2 unknown_status NCT06351696
The Effects of Bromelain Supplement in Patients With Ulcerative Colitis No drug interventions treatment Not Available recruiting NCT04753996
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients No drug interventions Not Available Not Available recruiting NCT03035058
Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease treatment 3 withdrawn NCT01879735
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT basic_science 1 completed NCT02978339
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) treatment 1 / 2 completed NCT00179439
NPDT Evaluation in Children With CFTR and (PSC) No drug interventions Not Available Not Available completed NCT02247622
Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis No drug interventions Not Available Not Available unknown_status NCT02701166
The Effect of Bezafibrate on Cholestatic Itch treatment 3 unknown_status NCT02446665
Disease Status in Primary Sclerosing Cholangitis by Elastography No drug interventions diagnostic Not Available unknown_status NCT02464020
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis basic_science 1 completed NCT05876182
Vancomycin in Primary Sclerosing Cholangitis in Italy treatment 2 recruiting NCT00951327
Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatogram (ERCP) No drug interventions Not Available Not Available completed NCT03216876
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis treatment 1 withdrawn NCT03722576
Vidofludimus Calcium for Primary Sclerosing Cholangitis treatment 2 completed NCT03069976
"Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" treatment Not Available completed NCT01085760
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis treatment 1 completed NCT02943460
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis treatment 2 completed NCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome No drug interventions Not Available Not Available recruiting NCT05295680
Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. treatment 2 recruiting NCT04133792
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC) treatment 3 recruiting NCT03046901
Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients prevention Not Available withdrawn NCT02137668
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin treatment 1 recruiting NCT03394781
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) treatment 2 terminated NCT06197308
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC treatment 0 recruiting NCT02736708
Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures No drug interventions Not Available Not Available completed